怡園酒業(08146.HK)與福建同源建設工程訂立釀酒廠建設合約
格隆匯 4 月 28日丨怡園酒業(08146.HK)公吿,於2021年4月28日,公司的間接全資附屬公司福建德熙與獨立第三方承包商福建省同源建設工程有限公司訂立建設合約,據此,承包商將負責釀酒廠建設工程,合約總額為人民幣2385.32萬元(不包括增值税)。
承包商於中國成立,主要從事(其中包括)與水利及水電建設、公路工程建設以及一般建築及施工有關的總承包工作。根據於公吿日期公開可得的資料,承包商由王養華、王春華及王永強分別持有40%、30%及30%。就董事經作出一切合理查詢後所深知、盡悉及確信,承包商及其最終實益擁有人為獨立於公司及其關連人士的第三方。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.